nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Chlorambucil—breast cancer	0.326	1	CrCtD
Melphalan—ovarian cancer—breast cancer	0.229	1	CtDrD
Melphalan—Alkylating Activity—Chlorambucil—breast cancer	0.172	0.5	CiPCiCtD
Melphalan—Alkylating Activity—Thiotepa—breast cancer	0.172	0.5	CiPCiCtD
Melphalan—SLC22A3—Irinotecan—breast cancer	0.0199	1	CbGbCtD
Melphalan—SLC7A5—mammary gland—breast cancer	0.00101	0.104	CbGeAlD
Melphalan—SLC7A5—nipple—breast cancer	0.000839	0.0863	CbGeAlD
Melphalan—Chlorambucil—GSTP1—breast cancer	0.000589	0.585	CrCbGaD
Melphalan—SLC7A5—epithelium—breast cancer	0.000565	0.0581	CbGeAlD
Melphalan—SLC7A5—skin of body—breast cancer	0.000537	0.0552	CbGeAlD
Melphalan—SLC7A5—Desoximetasone—Fluoxymesterone—breast cancer	0.000527	1	CbGdCrCtD
Melphalan—SLC22A3—nipple—breast cancer	0.000521	0.0535	CbGeAlD
Melphalan—SLC7A5—endometrium—breast cancer	0.000506	0.0521	CbGeAlD
Melphalan—SLC7A5—uterus—breast cancer	0.000467	0.048	CbGeAlD
Melphalan—SLC7A5—pituitary gland—breast cancer	0.000458	0.0471	CbGeAlD
Melphalan—SLC7A5—adipose tissue—breast cancer	0.000456	0.0469	CbGeAlD
Melphalan—SLC22A3—embryo—breast cancer	0.00043	0.0442	CbGeAlD
Melphalan—SLC7A5—female reproductive system—breast cancer	0.000419	0.0432	CbGeAlD
Melphalan—SLC7A5—adrenal gland—breast cancer	0.000409	0.0421	CbGeAlD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.000404	0.0243	CbGpPWpGaD
Melphalan—SLC7A5—bone marrow—breast cancer	0.000396	0.0407	CbGeAlD
Melphalan—SLC7A5—female gonad—breast cancer	0.000382	0.0393	CbGeAlD
Melphalan—SLC7A5—endocrine gland—breast cancer	0.000355	0.0365	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—GSTA2—breast cancer	0.000343	0.0207	CbGpPWpGaD
Melphalan—SLC22A3—endometrium—breast cancer	0.000314	0.0323	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—AHR—breast cancer	0.000299	0.018	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transport and metabolism—ABCB1—breast cancer	0.000288	0.0173	CbGpPWpGaD
Melphalan—SLC22A3—adipose tissue—breast cancer	0.000283	0.0291	CbGeAlD
Melphalan—SLC22A3—female reproductive system—breast cancer	0.00026	0.0268	CbGeAlD
Melphalan—SLC22A3—adrenal gland—breast cancer	0.000254	0.0261	CbGeAlD
Melphalan—SLC7A5—lymph node—breast cancer	0.000245	0.0252	CbGeAlD
Melphalan—SLC22A3—female gonad—breast cancer	0.000237	0.0244	CbGeAlD
Melphalan—SLC7A5—Basigin interactions—MMP1—breast cancer	0.000224	0.0135	CbGpPWpGaD
Melphalan—SLC22A3—endocrine gland—breast cancer	0.00022	0.0227	CbGeAlD
Melphalan—SLC7A5—Basigin interactions—CAV1—breast cancer	0.000215	0.0129	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NQO1—breast cancer	0.000211	0.0127	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000208	0.0125	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CYP1B1—breast cancer	0.000202	0.0122	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.000202	0.0122	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—breast cancer	0.000198	0.0119	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000197	0.0119	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NCOA1—breast cancer	0.000193	0.0116	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00018	0.0109	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00018	0.0109	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.000168	0.0101	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—HES1—breast cancer	0.000163	0.00979	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—GRB7—breast cancer	0.000162	0.00976	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—BAX—breast cancer	0.000158	0.00948	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CYP1A1—breast cancer	0.000153	0.00923	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.000153	0.00922	CbGpPWpGaD
Melphalan—SLC22A3—lymph node—breast cancer	0.000152	0.0157	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000149	0.009	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000148	0.00888	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000137	0.00823	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000132	0.00792	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000132	0.00792	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—GUCY1A2—breast cancer	0.00013	0.00782	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000127	0.00764	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000122	0.00736	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000113	0.00682	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—HRG—breast cancer	0.000106	0.00637	CbGpPWpGaD
Melphalan—Ibuprofen—BCL2—breast cancer	0.000102	0.102	CrCbGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.0001	0.00605	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.0001	0.00603	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—C1QBP—breast cancer	9.85e-05	0.00593	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—breast cancer	9.51e-05	0.00572	CbGpPWpGaD
Melphalan—Ibuprofen—ABCC1—breast cancer	9.27e-05	0.0922	CrCbGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A10—breast cancer	9.19e-05	0.00553	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC4A7—breast cancer	9.19e-05	0.00553	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A10—breast cancer	9.17e-05	0.00552	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC4A7—breast cancer	9.17e-05	0.00552	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CDKN1B—breast cancer	8.63e-05	0.0052	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—breast cancer	8.48e-05	0.00511	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—breast cancer	8.45e-05	0.00509	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUN—breast cancer	8.22e-05	0.00495	CbGpPWpGaD
Melphalan—Ibuprofen—CXCL8—breast cancer	8.2e-05	0.0815	CrCbGaD
Melphalan—SLC7A5—Hemostasis—RAD51B—breast cancer	8.03e-05	0.00483	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	7.64e-05	0.0046	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC39A7—breast cancer	7.61e-05	0.00458	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—COX11—breast cancer	7.6e-05	0.00457	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC39A7—breast cancer	7.6e-05	0.00457	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MMP1—breast cancer	7.45e-05	0.00448	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	7.37e-05	0.00444	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CAV1—breast cancer	7.14e-05	0.0043	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC22A18—breast cancer	6.96e-05	0.00419	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC22A18—breast cancer	6.95e-05	0.00418	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SERPINB2—breast cancer	6.82e-05	0.00411	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—RAD51C—breast cancer	6.82e-05	0.00411	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A2—breast cancer	6.82e-05	0.0041	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—FN1—breast cancer	6.8e-05	0.00409	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A5—breast cancer	6.7e-05	0.00404	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	6.7e-05	0.00404	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLCO1B1—breast cancer	6.69e-05	0.00403	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A5—breast cancer	6.69e-05	0.00403	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PDE2A—breast cancer	6.65e-05	0.004	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	6.59e-05	0.00397	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	6.46e-05	0.00389	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KDM1A—breast cancer	6.34e-05	0.00382	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	6.15e-05	0.0037	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—STIM1—breast cancer	6.08e-05	0.00366	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC39A6—breast cancer	5.77e-05	0.00347	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC39A6—breast cancer	5.76e-05	0.00347	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC5A5—breast cancer	5.46e-05	0.00329	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—F3—breast cancer	5.32e-05	0.0032	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A1—breast cancer	5.28e-05	0.00318	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ATP7B—breast cancer	5.27e-05	0.00317	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC28A1—breast cancer	5.11e-05	0.00307	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CB—breast cancer	4.98e-05	0.003	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCC1—breast cancer	4.89e-05	0.00295	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A10—breast cancer	4.67e-05	0.00281	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC4A7—breast cancer	4.67e-05	0.00281	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CFL1—breast cancer	4.44e-05	0.00267	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—GRB7—breast cancer	4.4e-05	0.00265	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS1—breast cancer	4.19e-05	0.0416	CrCbGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TUBB3—breast cancer	4.16e-05	0.00251	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALDOA—breast cancer	4.15e-05	0.0025	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFC—breast cancer	4.15e-05	0.0025	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SRC—breast cancer	3.99e-05	0.0024	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC39A7—breast cancer	3.87e-05	0.00233	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—COX11—breast cancer	3.87e-05	0.00233	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC22A18—breast cancer	3.54e-05	0.00213	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TGFB2—breast cancer	3.49e-05	0.0021	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—THBS1—breast cancer	3.48e-05	0.00209	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A2—breast cancer	3.47e-05	0.00209	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A2—breast cancer	3.46e-05	0.00208	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—GATA3—breast cancer	3.43e-05	0.00206	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A5—breast cancer	3.41e-05	0.00205	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLCO1B1—breast cancer	3.41e-05	0.00205	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCG2—breast cancer	3.39e-05	0.00204	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—KRAS—breast cancer	3.31e-05	0.00199	CbGpPWpGaD
Melphalan—L-DOPA—CYP2D6—breast cancer	3.27e-05	0.0325	CrCbGaD
Melphalan—SLC7A5—Hemostasis—IFNB1—breast cancer	3.08e-05	0.00185	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—breast cancer	3.04e-05	0.00183	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TFRC—breast cancer	3.02e-05	0.00182	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC39A6—breast cancer	2.93e-05	0.00177	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—NCOA2—breast cancer	2.91e-05	0.00175	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLAUR—breast cancer	2.83e-05	0.0017	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—HRAS—breast cancer	2.81e-05	0.00169	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—breast cancer	2.78e-05	0.00168	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.78e-05	0.00167	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLG—breast cancer	2.76e-05	0.00166	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A1—breast cancer	2.69e-05	0.00162	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ATP7B—breast cancer	2.68e-05	0.00161	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.68e-05	0.00161	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PDGFA—breast cancer	2.62e-05	0.00158	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—breast cancer	2.61e-05	0.00157	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ITPR1—breast cancer	2.54e-05	0.00153	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ABL1—breast cancer	2.53e-05	0.00152	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCC1—breast cancer	2.49e-05	0.0015	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—NCOA1—breast cancer	2.45e-05	0.00148	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS2—breast cancer	2.39e-05	0.0238	CrCbGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PLG—breast cancer	2.39e-05	0.00144	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLA2G4A—breast cancer	2.37e-05	0.00143	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—HGF—breast cancer	2.37e-05	0.00143	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CSF2—breast cancer	2.35e-05	0.00141	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—HMOX1—breast cancer	2.21e-05	0.00133	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SYNJ2—breast cancer	2.19e-05	0.00132	CbGpPWpGaD
Melphalan—Ibuprofen—ALB—breast cancer	2.13e-05	0.0212	CrCbGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TUBB3—breast cancer	2.12e-05	0.00128	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCB1—breast cancer	2.12e-05	0.00127	CbGpPWpGaD
Melphalan—Ibuprofen—ABCB1—breast cancer	2.03e-05	0.0202	CrCbGaD
Melphalan—SLC22A3—Metabolism—NDUFS3—breast cancer	2.03e-05	0.00122	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MMP1—breast cancer	2.02e-05	0.00122	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CDK2—breast cancer	1.98e-05	0.00119	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLAU—breast cancer	1.98e-05	0.00119	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CAV1—breast cancer	1.94e-05	0.00117	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CHST9—breast cancer	1.91e-05	0.00115	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—FN1—breast cancer	1.84e-05	0.00111	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS2—breast cancer	1.82e-05	0.0011	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—COX11—breast cancer	1.81e-05	0.00109	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.76e-05	0.00106	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CG—breast cancer	1.76e-05	0.00106	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—EGF—breast cancer	1.74e-05	0.00105	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCG2—breast cancer	1.73e-05	0.00104	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CDA—breast cancer	1.66e-05	0.000998	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SHMT1—breast cancer	1.66e-05	0.000998	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IGF1—breast cancer	1.61e-05	0.000972	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT2—breast cancer	1.61e-05	0.000971	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC2A5—breast cancer	1.6e-05	0.00096	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLCO1B1—breast cancer	1.6e-05	0.00096	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CD—breast cancer	1.55e-05	0.000933	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APRT—breast cancer	1.54e-05	0.000928	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TFRC—breast cancer	1.54e-05	0.000927	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SERPINE1—breast cancer	1.53e-05	0.000923	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALB—breast cancer	1.53e-05	0.000921	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—NCOA2—breast cancer	1.48e-05	0.000893	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS3—breast cancer	1.46e-05	0.000881	CbGpPWpGaD
Melphalan—Rash—Vinorelbine—breast cancer	1.46e-05	0.000276	CcSEcCtD
Melphalan—Dermatitis—Vinorelbine—breast cancer	1.46e-05	0.000275	CcSEcCtD
Melphalan—Hypotension—Paclitaxel—breast cancer	1.45e-05	0.000275	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—breast cancer	1.45e-05	0.000274	CcSEcCtD
Melphalan—Urticaria—Fluorouracil—breast cancer	1.45e-05	0.000274	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ESRRA—breast cancer	1.45e-05	0.000872	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ANGPTL4—breast cancer	1.45e-05	0.000872	CbGpPWpGaD
Melphalan—Leukopenia—Docetaxel—breast cancer	1.45e-05	0.000273	CcSEcCtD
Melphalan—Anaemia—Capecitabine—breast cancer	1.44e-05	0.000273	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Paclitaxel—breast cancer	1.42e-05	0.000268	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.41e-05	0.000851	CbGpPWpGaD
Melphalan—Cough—Docetaxel—breast cancer	1.41e-05	0.000266	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—breast cancer	1.41e-05	0.000266	CcSEcCtD
Melphalan—Hypersensitivity—Mitoxantrone—breast cancer	1.4e-05	0.000266	CcSEcCtD
Melphalan—Hypersensitivity—Irinotecan—breast cancer	1.4e-05	0.000266	CcSEcCtD
Melphalan—Vomiting—Thiotepa—breast cancer	1.4e-05	0.000265	CcSEcCtD
Melphalan—Leukopenia—Capecitabine—breast cancer	1.4e-05	0.000265	CcSEcCtD
Melphalan—Convulsion—Docetaxel—breast cancer	1.4e-05	0.000265	CcSEcCtD
Melphalan—Paraesthesia—Paclitaxel—breast cancer	1.4e-05	0.000264	CcSEcCtD
Melphalan—Rash—Thiotepa—breast cancer	1.39e-05	0.000263	CcSEcCtD
Melphalan—Dermatitis—Thiotepa—breast cancer	1.39e-05	0.000263	CcSEcCtD
Melphalan—Dyspnoea—Paclitaxel—breast cancer	1.39e-05	0.000262	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—RAF1—breast cancer	1.38e-05	0.000833	CbGpPWpGaD
Melphalan—Myalgia—Docetaxel—breast cancer	1.37e-05	0.00026	CcSEcCtD
Melphalan—Chest pain—Docetaxel—breast cancer	1.37e-05	0.00026	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—breast cancer	1.37e-05	0.00026	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HADHB—breast cancer	1.37e-05	0.000827	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPI—breast cancer	1.37e-05	0.000827	CbGpPWpGaD
Melphalan—Nausea—Vinorelbine—breast cancer	1.37e-05	0.00026	CcSEcCtD
Melphalan—Dyspepsia—Paclitaxel—breast cancer	1.37e-05	0.000259	CcSEcCtD
Melphalan—Asthenia—Mitoxantrone—breast cancer	1.37e-05	0.000259	CcSEcCtD
Melphalan—Asthenia—Irinotecan—breast cancer	1.37e-05	0.000259	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.37e-05	0.000822	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Epirubicin—breast cancer	1.37e-05	0.000258	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	1.37e-05	0.000258	CcSEcCtD
Melphalan—Cough—Capecitabine—breast cancer	1.36e-05	0.000258	CcSEcCtD
Melphalan—Jaundice—Epirubicin—breast cancer	1.36e-05	0.000257	CcSEcCtD
Melphalan—Stomatitis—Epirubicin—breast cancer	1.36e-05	0.000257	CcSEcCtD
Melphalan—Neutropenia—Doxorubicin—breast cancer	1.35e-05	0.000256	CcSEcCtD
Melphalan—Decreased appetite—Paclitaxel—breast cancer	1.35e-05	0.000256	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PIK3CB—breast cancer	1.35e-05	0.000813	CbGpPWpGaD
Melphalan—Hypersensitivity—Fluorouracil—breast cancer	1.35e-05	0.000254	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—breast cancer	1.34e-05	0.000254	CcSEcCtD
Melphalan—Gastrointestinal disorder—Paclitaxel—breast cancer	1.34e-05	0.000254	CcSEcCtD
Melphalan—Fatigue—Paclitaxel—breast cancer	1.34e-05	0.000253	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—breast cancer	1.34e-05	0.000253	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—breast cancer	1.34e-05	0.000253	CcSEcCtD
Melphalan—Asthenia—Gemcitabine—breast cancer	1.33e-05	0.000252	CcSEcCtD
Melphalan—Myalgia—Capecitabine—breast cancer	1.33e-05	0.000252	CcSEcCtD
Melphalan—Chest pain—Capecitabine—breast cancer	1.33e-05	0.000252	CcSEcCtD
Melphalan—Pain—Paclitaxel—breast cancer	1.33e-05	0.000251	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—breast cancer	1.33e-05	0.000799	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—breast cancer	1.32e-05	0.000797	CbGpPWpGaD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	1.32e-05	0.00025	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—breast cancer	1.32e-05	0.00025	CcSEcCtD
Melphalan—Hepatobiliary disease—Epirubicin—breast cancer	1.32e-05	0.000249	CcSEcCtD
Melphalan—Anaphylactic shock—Docetaxel—breast cancer	1.32e-05	0.000249	CcSEcCtD
Melphalan—Oedema—Docetaxel—breast cancer	1.32e-05	0.000249	CcSEcCtD
Melphalan—Pruritus—Gemcitabine—breast cancer	1.31e-05	0.000248	CcSEcCtD
Melphalan—Nausea—Thiotepa—breast cancer	1.31e-05	0.000248	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—breast cancer	1.31e-05	0.000248	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ALDH1A1—breast cancer	1.31e-05	0.000789	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALDH7A1—breast cancer	1.31e-05	0.000789	CbGpPWpGaD
Melphalan—Infection—Docetaxel—breast cancer	1.31e-05	0.000248	CcSEcCtD
Melphalan—Diarrhoea—Irinotecan—breast cancer	1.3e-05	0.000247	CcSEcCtD
Melphalan—Diarrhoea—Mitoxantrone—breast cancer	1.3e-05	0.000247	CcSEcCtD
Melphalan—Pruritus—Fluorouracil—breast cancer	1.29e-05	0.000244	CcSEcCtD
Melphalan—Thrombocytopenia—Docetaxel—breast cancer	1.29e-05	0.000244	CcSEcCtD
Melphalan—Tachycardia—Docetaxel—breast cancer	1.29e-05	0.000243	CcSEcCtD
Melphalan—Skin disorder—Docetaxel—breast cancer	1.28e-05	0.000242	CcSEcCtD
Melphalan—Oedema—Capecitabine—breast cancer	1.28e-05	0.000241	CcSEcCtD
Melphalan—Diarrhoea—Gemcitabine—breast cancer	1.27e-05	0.00024	CcSEcCtD
Melphalan—Infection—Capecitabine—breast cancer	1.27e-05	0.00024	CcSEcCtD
Melphalan—Neuropathy peripheral—Doxorubicin—breast cancer	1.26e-05	0.000239	CcSEcCtD
Melphalan—Haemoglobin—Epirubicin—breast cancer	1.26e-05	0.000238	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—breast cancer	1.26e-05	0.000238	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—breast cancer	1.26e-05	0.000238	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ADSL—breast cancer	1.26e-05	0.000756	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PHGDH—breast cancer	1.26e-05	0.000756	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—UMPS—breast cancer	1.26e-05	0.000756	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NME1—breast cancer	1.26e-05	0.000756	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FHL2—breast cancer	1.26e-05	0.000756	CbGpPWpGaD
Melphalan—Anorexia—Docetaxel—breast cancer	1.26e-05	0.000238	CcSEcCtD
Melphalan—Haemorrhage—Epirubicin—breast cancer	1.25e-05	0.000237	CcSEcCtD
Melphalan—Hepatitis—Epirubicin—breast cancer	1.25e-05	0.000237	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—NCOA1—breast cancer	1.25e-05	0.000752	CbGpPWpGaD
Melphalan—Diarrhoea—Fluorouracil—breast cancer	1.25e-05	0.000236	CcSEcCtD
Melphalan—Thrombocytopenia—Capecitabine—breast cancer	1.25e-05	0.000236	CcSEcCtD
Melphalan—Tachycardia—Capecitabine—breast cancer	1.25e-05	0.000235	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IL2—breast cancer	1.24e-05	0.000747	CbGpPWpGaD
Melphalan—Skin disorder—Capecitabine—breast cancer	1.24e-05	0.000234	CcSEcCtD
Melphalan—Urinary tract disorder—Epirubicin—breast cancer	1.24e-05	0.000234	CcSEcCtD
Melphalan—Urticaria—Paclitaxel—breast cancer	1.24e-05	0.000234	CcSEcCtD
Melphalan—SLC22A3—Metabolism—BRIP1—breast cancer	1.23e-05	0.000741	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LDHB—breast cancer	1.23e-05	0.000741	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HPSE—breast cancer	1.23e-05	0.000741	CbGpPWpGaD
Melphalan—Hypotension—Docetaxel—breast cancer	1.23e-05	0.000233	CcSEcCtD
Melphalan—Connective tissue disorder—Epirubicin—breast cancer	1.23e-05	0.000232	CcSEcCtD
Melphalan—Urethral disorder—Epirubicin—breast cancer	1.23e-05	0.000232	CcSEcCtD
Melphalan—Hepatobiliary disease—Doxorubicin—breast cancer	1.22e-05	0.000231	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PLG—breast cancer	1.22e-05	0.000733	CbGpPWpGaD
Melphalan—Anorexia—Capecitabine—breast cancer	1.22e-05	0.00023	CcSEcCtD
Melphalan—Vomiting—Mitoxantrone—breast cancer	1.21e-05	0.000229	CcSEcCtD
Melphalan—Vomiting—Irinotecan—breast cancer	1.21e-05	0.000229	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—breast cancer	1.21e-05	0.000228	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—breast cancer	1.2e-05	0.000228	CcSEcCtD
Melphalan—Rash—Irinotecan—breast cancer	1.2e-05	0.000227	CcSEcCtD
Melphalan—Rash—Mitoxantrone—breast cancer	1.2e-05	0.000227	CcSEcCtD
Melphalan—Dermatitis—Irinotecan—breast cancer	1.2e-05	0.000227	CcSEcCtD
Melphalan—Dermatitis—Mitoxantrone—breast cancer	1.2e-05	0.000227	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Docetaxel—breast cancer	1.2e-05	0.000227	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—RAF1—breast cancer	1.2e-05	0.000721	CbGpPWpGaD
Melphalan—Hypotension—Capecitabine—breast cancer	1.19e-05	0.000225	CcSEcCtD
Melphalan—Paraesthesia—Docetaxel—breast cancer	1.18e-05	0.000224	CcSEcCtD
Melphalan—Alopecia—Methotrexate—breast cancer	1.18e-05	0.000223	CcSEcCtD
Melphalan—Vomiting—Gemcitabine—breast cancer	1.18e-05	0.000223	CcSEcCtD
Melphalan—Dyspnoea—Docetaxel—breast cancer	1.17e-05	0.000222	CcSEcCtD
Melphalan—Rash—Gemcitabine—breast cancer	1.17e-05	0.000221	CcSEcCtD
Melphalan—Dermatitis—Gemcitabine—breast cancer	1.17e-05	0.000221	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HMMR—breast cancer	1.17e-05	0.000703	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTA3—breast cancer	1.17e-05	0.000703	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCC1—breast cancer	1.17e-05	0.000703	CbGpPWpGaD
Melphalan—Haemoglobin—Doxorubicin—breast cancer	1.16e-05	0.00022	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Capecitabine—breast cancer	1.16e-05	0.00022	CcSEcCtD
Melphalan—Flushing—Epirubicin—breast cancer	1.16e-05	0.00022	CcSEcCtD
Melphalan—Vomiting—Fluorouracil—breast cancer	1.16e-05	0.000219	CcSEcCtD
Melphalan—Dyspepsia—Docetaxel—breast cancer	1.16e-05	0.000219	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—breast cancer	1.16e-05	0.000219	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—breast cancer	1.16e-05	0.000219	CcSEcCtD
Melphalan—Rash—Fluorouracil—breast cancer	1.15e-05	0.000218	CcSEcCtD
Melphalan—Dermatitis—Fluorouracil—breast cancer	1.15e-05	0.000217	CcSEcCtD
Melphalan—Paraesthesia—Capecitabine—breast cancer	1.15e-05	0.000217	CcSEcCtD
Melphalan—Decreased appetite—Docetaxel—breast cancer	1.15e-05	0.000217	CcSEcCtD
Melphalan—Hypersensitivity—Paclitaxel—breast cancer	1.15e-05	0.000217	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—breast cancer	1.14e-05	0.000216	CcSEcCtD
Melphalan—Gastrointestinal disorder—Docetaxel—breast cancer	1.14e-05	0.000215	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—breast cancer	1.14e-05	0.000215	CcSEcCtD
Melphalan—Dyspnoea—Capecitabine—breast cancer	1.14e-05	0.000215	CcSEcCtD
Melphalan—Fatigue—Docetaxel—breast cancer	1.14e-05	0.000215	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—breast cancer	1.13e-05	0.000215	CcSEcCtD
Melphalan—Nausea—Irinotecan—breast cancer	1.13e-05	0.000214	CcSEcCtD
Melphalan—Nausea—Mitoxantrone—breast cancer	1.13e-05	0.000214	CcSEcCtD
Melphalan—SLC22A3—Metabolism—PPARGC1B—breast cancer	1.13e-05	0.000681	CbGpPWpGaD
Melphalan—Immune system disorder—Epirubicin—breast cancer	1.13e-05	0.000214	CcSEcCtD
Melphalan—Mediastinal disorder—Epirubicin—breast cancer	1.13e-05	0.000213	CcSEcCtD
Melphalan—Pain—Docetaxel—breast cancer	1.13e-05	0.000213	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—HMOX1—breast cancer	1.12e-05	0.000676	CbGpPWpGaD
Melphalan—Dyspepsia—Capecitabine—breast cancer	1.12e-05	0.000212	CcSEcCtD
Melphalan—Arrhythmia—Epirubicin—breast cancer	1.12e-05	0.000211	CcSEcCtD
Melphalan—Asthenia—Paclitaxel—breast cancer	1.12e-05	0.000211	CcSEcCtD
Melphalan—Decreased appetite—Capecitabine—breast cancer	1.11e-05	0.00021	CcSEcCtD
Melphalan—Alopecia—Epirubicin—breast cancer	1.11e-05	0.000209	CcSEcCtD
Melphalan—Nausea—Gemcitabine—breast cancer	1.1e-05	0.000209	CcSEcCtD
Melphalan—Gastrointestinal disorder—Capecitabine—breast cancer	1.1e-05	0.000208	CcSEcCtD
Melphalan—Fatigue—Capecitabine—breast cancer	1.1e-05	0.000208	CcSEcCtD
Melphalan—Pruritus—Paclitaxel—breast cancer	1.1e-05	0.000208	CcSEcCtD
Melphalan—Pain—Capecitabine—breast cancer	1.09e-05	0.000206	CcSEcCtD
Melphalan—Nausea—Fluorouracil—breast cancer	1.08e-05	0.000205	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SRC—breast cancer	1.08e-05	0.000652	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCB1—breast cancer	1.08e-05	0.000649	CbGpPWpGaD
Melphalan—Anaemia—Methotrexate—breast cancer	1.08e-05	0.000203	CcSEcCtD
Melphalan—Flushing—Doxorubicin—breast cancer	1.07e-05	0.000203	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CA9—breast cancer	1.07e-05	0.000643	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTA4—breast cancer	1.07e-05	0.000643	CbGpPWpGaD
Melphalan—Diarrhoea—Paclitaxel—breast cancer	1.06e-05	0.000201	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—VEGFA—breast cancer	1.05e-05	0.000635	CbGpPWpGaD
Melphalan—Immune system disorder—Doxorubicin—breast cancer	1.05e-05	0.000198	CcSEcCtD
Melphalan—Mediastinal disorder—Doxorubicin—breast cancer	1.04e-05	0.000197	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—breast cancer	1.04e-05	0.000197	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GSTA2—breast cancer	1.04e-05	0.000627	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPX2—breast cancer	1.04e-05	0.000627	CbGpPWpGaD
Melphalan—Arrhythmia—Doxorubicin—breast cancer	1.03e-05	0.000196	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GPX4—breast cancer	1.03e-05	0.000619	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SULT1A1—breast cancer	1.03e-05	0.000619	CbGpPWpGaD
Melphalan—Alopecia—Doxorubicin—breast cancer	1.02e-05	0.000193	CcSEcCtD
Melphalan—Cough—Methotrexate—breast cancer	1.02e-05	0.000192	CcSEcCtD
Melphalan—Urticaria—Capecitabine—breast cancer	1.01e-05	0.000192	CcSEcCtD
Melphalan—Convulsion—Methotrexate—breast cancer	1.01e-05	0.000191	CcSEcCtD
Melphalan—Anaemia—Epirubicin—breast cancer	1.01e-05	0.00019	CcSEcCtD
Melphalan—SLC22A3—Metabolism—IDH1—breast cancer	1e-05	0.000604	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTA1—breast cancer	1e-05	0.000604	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK3—breast cancer	9.98e-06	0.0006	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NAT2—breast cancer	9.93e-06	0.000598	CbGpPWpGaD
Melphalan—Chest pain—Methotrexate—breast cancer	9.91e-06	0.000187	CcSEcCtD
Melphalan—Myalgia—Methotrexate—breast cancer	9.91e-06	0.000187	CcSEcCtD
Melphalan—Vomiting—Paclitaxel—breast cancer	9.89e-06	0.000187	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9.84e-06	0.000186	CcSEcCtD
Melphalan—Rash—Paclitaxel—breast cancer	9.8e-06	0.000185	CcSEcCtD
Melphalan—Dermatitis—Paclitaxel—breast cancer	9.79e-06	0.000185	CcSEcCtD
Melphalan—Leukopenia—Epirubicin—breast cancer	9.75e-06	0.000184	CcSEcCtD
Melphalan—Hypersensitivity—Docetaxel—breast cancer	9.71e-06	0.000184	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—TGFB1—breast cancer	9.68e-06	0.000583	CbGpPWpGaD
Melphalan—Cough—Epirubicin—breast cancer	9.5e-06	0.00018	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—breast cancer	9.5e-06	0.00018	CcSEcCtD
Melphalan—Asthenia—Docetaxel—breast cancer	9.45e-06	0.000179	CcSEcCtD
Melphalan—Convulsion—Epirubicin—breast cancer	9.44e-06	0.000178	CcSEcCtD
Melphalan—Infection—Methotrexate—breast cancer	9.44e-06	0.000178	CcSEcCtD
Melphalan—Hypersensitivity—Capecitabine—breast cancer	9.4e-06	0.000178	CcSEcCtD
Melphalan—Pruritus—Docetaxel—breast cancer	9.32e-06	0.000176	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—breast cancer	9.31e-06	0.000176	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—breast cancer	9.3e-06	0.000176	CcSEcCtD
Melphalan—Myalgia—Epirubicin—breast cancer	9.27e-06	0.000175	CcSEcCtD
Melphalan—Chest pain—Epirubicin—breast cancer	9.27e-06	0.000175	CcSEcCtD
Melphalan—Nausea—Paclitaxel—breast cancer	9.24e-06	0.000175	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—breast cancer	9.23e-06	0.000174	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.21e-06	0.000174	CcSEcCtD
Melphalan—Asthenia—Capecitabine—breast cancer	9.15e-06	0.000173	CcSEcCtD
Melphalan—Anorexia—Methotrexate—breast cancer	9.05e-06	0.000171	CcSEcCtD
Melphalan—Pruritus—Capecitabine—breast cancer	9.03e-06	0.000171	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—breast cancer	9.02e-06	0.000171	CcSEcCtD
Melphalan—Diarrhoea—Docetaxel—breast cancer	9.02e-06	0.00017	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—KRAS—breast cancer	8.96e-06	0.00054	CbGpPWpGaD
Melphalan—Oedema—Epirubicin—breast cancer	8.89e-06	0.000168	CcSEcCtD
Melphalan—Anaphylactic shock—Epirubicin—breast cancer	8.89e-06	0.000168	CcSEcCtD
Melphalan—Hypotension—Methotrexate—breast cancer	8.88e-06	0.000168	CcSEcCtD
Melphalan—Infection—Epirubicin—breast cancer	8.83e-06	0.000167	CcSEcCtD
Melphalan—Cough—Doxorubicin—breast cancer	8.79e-06	0.000166	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—breast cancer	8.73e-06	0.000165	CcSEcCtD
Melphalan—Diarrhoea—Capecitabine—breast cancer	8.73e-06	0.000165	CcSEcCtD
Melphalan—SLC22A3—Metabolism—DPYD—breast cancer	8.71e-06	0.000524	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MED12—breast cancer	8.71e-06	0.000524	CbGpPWpGaD
Melphalan—Thrombocytopenia—Epirubicin—breast cancer	8.7e-06	0.000165	CcSEcCtD
Melphalan—Tachycardia—Epirubicin—breast cancer	8.68e-06	0.000164	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—breast cancer	8.65e-06	0.000164	CcSEcCtD
Melphalan—Skin disorder—Epirubicin—breast cancer	8.63e-06	0.000163	CcSEcCtD
Melphalan—Myalgia—Doxorubicin—breast cancer	8.58e-06	0.000162	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—breast cancer	8.58e-06	0.000162	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ALDOA—breast cancer	8.57e-06	0.000516	CbGpPWpGaD
Melphalan—Paraesthesia—Methotrexate—breast cancer	8.53e-06	0.000161	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.52e-06	0.000161	CcSEcCtD
Melphalan—Anorexia—Epirubicin—breast cancer	8.47e-06	0.00016	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—breast cancer	8.47e-06	0.00016	CcSEcCtD
Melphalan—Vomiting—Docetaxel—breast cancer	8.38e-06	0.000158	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—breast cancer	8.36e-06	0.000158	CcSEcCtD
Melphalan—SLC22A3—Metabolism—NCOA3—breast cancer	8.32e-06	0.000501	CbGpPWpGaD
Melphalan—Rash—Docetaxel—breast cancer	8.31e-06	0.000157	CcSEcCtD
Melphalan—Hypotension—Epirubicin—breast cancer	8.31e-06	0.000157	CcSEcCtD
Melphalan—Dermatitis—Docetaxel—breast cancer	8.3e-06	0.000157	CcSEcCtD
Melphalan—SLC22A3—Metabolism—SLC2A2—breast cancer	8.26e-06	0.000497	CbGpPWpGaD
Melphalan—Decreased appetite—Methotrexate—breast cancer	8.26e-06	0.000156	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PIK3CA—breast cancer	8.24e-06	0.000496	CbGpPWpGaD
Melphalan—Anaphylactic shock—Doxorubicin—breast cancer	8.22e-06	0.000156	CcSEcCtD
Melphalan—Oedema—Doxorubicin—breast cancer	8.22e-06	0.000156	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—breast cancer	8.2e-06	0.000155	CcSEcCtD
Melphalan—Fatigue—Methotrexate—breast cancer	8.19e-06	0.000155	CcSEcCtD
Melphalan—Infection—Doxorubicin—breast cancer	8.17e-06	0.000154	CcSEcCtD
Melphalan—Pain—Methotrexate—breast cancer	8.12e-06	0.000154	CcSEcCtD
Melphalan—Vomiting—Capecitabine—breast cancer	8.11e-06	0.000153	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Epirubicin—breast cancer	8.1e-06	0.000153	CcSEcCtD
Melphalan—SLC22A3—Metabolism—MTR—breast cancer	8.09e-06	0.000487	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCG2—breast cancer	8.09e-06	0.000487	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CPT1A—breast cancer	8.09e-06	0.000487	CbGpPWpGaD
Melphalan—Thrombocytopenia—Doxorubicin—breast cancer	8.05e-06	0.000152	CcSEcCtD
Melphalan—Rash—Capecitabine—breast cancer	8.04e-06	0.000152	CcSEcCtD
Melphalan—Dermatitis—Capecitabine—breast cancer	8.04e-06	0.000152	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—breast cancer	8.03e-06	0.000152	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—breast cancer	7.99e-06	0.000151	CcSEcCtD
Melphalan—Paraesthesia—Epirubicin—breast cancer	7.98e-06	0.000151	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—TP53—breast cancer	7.97e-06	0.00048	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HPGDS—breast cancer	7.94e-06	0.000478	CbGpPWpGaD
Melphalan—Dyspnoea—Epirubicin—breast cancer	7.92e-06	0.00015	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HBA1—breast cancer	7.89e-06	0.000475	CbGpPWpGaD
Melphalan—Anorexia—Doxorubicin—breast cancer	7.84e-06	0.000148	CcSEcCtD
Melphalan—Nausea—Docetaxel—breast cancer	7.83e-06	0.000148	CcSEcCtD
Melphalan—Dyspepsia—Epirubicin—breast cancer	7.82e-06	0.000148	CcSEcCtD
Melphalan—Decreased appetite—Epirubicin—breast cancer	7.73e-06	0.000146	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ACHE—breast cancer	7.7e-06	0.000463	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTT1—breast cancer	7.7e-06	0.000463	CbGpPWpGaD
Melphalan—Hypotension—Doxorubicin—breast cancer	7.69e-06	0.000145	CcSEcCtD
Melphalan—Gastrointestinal disorder—Epirubicin—breast cancer	7.67e-06	0.000145	CcSEcCtD
Melphalan—Fatigue—Epirubicin—breast cancer	7.66e-06	0.000145	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—HRAS—breast cancer	7.62e-06	0.000459	CbGpPWpGaD
Melphalan—Pain—Epirubicin—breast cancer	7.6e-06	0.000144	CcSEcCtD
Melphalan—Nausea—Capecitabine—breast cancer	7.58e-06	0.000143	CcSEcCtD
Melphalan—Urticaria—Methotrexate—breast cancer	7.55e-06	0.000143	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.49e-06	0.000142	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—breast cancer	7.39e-06	0.00014	CcSEcCtD
Melphalan—Dyspnoea—Doxorubicin—breast cancer	7.33e-06	0.000139	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CYP17A1—breast cancer	7.29e-06	0.000439	CbGpPWpGaD
Melphalan—Dyspepsia—Doxorubicin—breast cancer	7.24e-06	0.000137	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ENO1—breast cancer	7.21e-06	0.000434	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS1—breast cancer	7.21e-06	0.000434	CbGpPWpGaD
Melphalan—Decreased appetite—Doxorubicin—breast cancer	7.15e-06	0.000135	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—breast cancer	7.1e-06	0.000134	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—breast cancer	7.09e-06	0.000134	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CYP2D6—breast cancer	7.08e-06	0.000426	CbGpPWpGaD
Melphalan—Urticaria—Epirubicin—breast cancer	7.06e-06	0.000134	CcSEcCtD
Melphalan—Pain—Doxorubicin—breast cancer	7.03e-06	0.000133	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—breast cancer	7e-06	0.000132	CcSEcCtD
Melphalan—SLC22A3—Metabolism—NCOA2—breast cancer	6.94e-06	0.000418	CbGpPWpGaD
Melphalan—Asthenia—Methotrexate—breast cancer	6.81e-06	0.000129	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—breast cancer	6.75e-06	0.000406	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FASN—breast cancer	6.74e-06	0.000405	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT1—breast cancer	6.73e-06	0.000405	CbGpPWpGaD
Melphalan—Pruritus—Methotrexate—breast cancer	6.72e-06	0.000127	CcSEcCtD
Melphalan—SLC22A3—Metabolism—BCHE—breast cancer	6.71e-06	0.000404	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC5A5—breast cancer	6.63e-06	0.000399	CbGpPWpGaD
Melphalan—Hypersensitivity—Epirubicin—breast cancer	6.55e-06	0.000124	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—breast cancer	6.53e-06	0.000124	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—breast cancer	6.5e-06	0.000123	CcSEcCtD
Melphalan—SLC22A3—Metabolism—SLC2A1—breast cancer	6.4e-06	0.000385	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NQO1—breast cancer	6.4e-06	0.000385	CbGpPWpGaD
Melphalan—Asthenia—Epirubicin—breast cancer	6.38e-06	0.000121	CcSEcCtD
Melphalan—Pruritus—Epirubicin—breast cancer	6.29e-06	0.000119	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CYP3A4—breast cancer	6.24e-06	0.000376	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP1B1—breast cancer	6.13e-06	0.000369	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—RAF1—breast cancer	6.1e-06	0.000367	CbGpPWpGaD
Melphalan—Diarrhoea—Epirubicin—breast cancer	6.08e-06	0.000115	CcSEcCtD
Melphalan—Hypersensitivity—Doxorubicin—breast cancer	6.06e-06	0.000115	CcSEcCtD
Melphalan—Vomiting—Methotrexate—breast cancer	6.04e-06	0.000114	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HSP90AA1—breast cancer	6.02e-06	0.000362	CbGpPWpGaD
Melphalan—Rash—Methotrexate—breast cancer	5.99e-06	0.000113	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—breast cancer	5.98e-06	0.000113	CcSEcCtD
Melphalan—Asthenia—Doxorubicin—breast cancer	5.9e-06	0.000112	CcSEcCtD
Melphalan—SLC22A3—Metabolism—NCOA1—breast cancer	5.85e-06	0.000352	CbGpPWpGaD
Melphalan—Pruritus—Doxorubicin—breast cancer	5.82e-06	0.00011	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CYP19A1—breast cancer	5.77e-06	0.000347	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—STK11—breast cancer	5.77e-06	0.000347	CbGpPWpGaD
Melphalan—Vomiting—Epirubicin—breast cancer	5.65e-06	0.000107	CcSEcCtD
Melphalan—Nausea—Methotrexate—breast cancer	5.64e-06	0.000107	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—breast cancer	5.63e-06	0.000106	CcSEcCtD
Melphalan—Rash—Epirubicin—breast cancer	5.6e-06	0.000106	CcSEcCtD
Melphalan—Dermatitis—Epirubicin—breast cancer	5.6e-06	0.000106	CcSEcCtD
Melphalan—SLC22A3—Metabolism—COMT—breast cancer	5.36e-06	0.000323	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTP1—breast cancer	5.34e-06	0.000321	CbGpPWpGaD
Melphalan—Nausea—Epirubicin—breast cancer	5.28e-06	9.98e-05	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HMOX1—breast cancer	5.26e-06	0.000317	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ITPR1—breast cancer	5.25e-06	0.000316	CbGpPWpGaD
Melphalan—Vomiting—Doxorubicin—breast cancer	5.23e-06	9.89e-05	CcSEcCtD
Melphalan—Rash—Doxorubicin—breast cancer	5.19e-06	9.8e-05	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—breast cancer	5.18e-06	9.8e-05	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ABCB1—breast cancer	5.05e-06	0.000304	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—TYMS—breast cancer	4.96e-06	0.000299	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLA2G4A—breast cancer	4.9e-06	0.000295	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NCOR1—breast cancer	4.9e-06	0.000295	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTM1—breast cancer	4.9e-06	0.000295	CbGpPWpGaD
Melphalan—Nausea—Doxorubicin—breast cancer	4.89e-06	9.24e-05	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GPX1—breast cancer	4.7e-06	0.000283	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP1A1—breast cancer	4.65e-06	0.00028	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ERCC2—breast cancer	4.61e-06	0.000278	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTHFR—breast cancer	4.33e-06	0.000261	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAV1—breast cancer	4e-06	0.000241	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CG—breast cancer	3.64e-06	0.000219	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CD—breast cancer	3.2e-06	0.000193	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—breast cancer	3.16e-06	0.00019	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NOS3—breast cancer	3.02e-06	0.000182	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CB—breast cancer	2.79e-06	0.000168	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—breast cancer	2.76e-06	0.000166	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTEN—breast cancer	2.41e-06	0.000145	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CA—breast cancer	1.7e-06	0.000102	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKT1—breast cancer	1.39e-06	8.36e-05	CbGpPWpGaD
